Cost Drivers in Patients with Classic Congenital Adrenal Hyperplasia (CAH)

MFarrar , C O’Donoghue , E Paiewonsky , C Yonan , R Nathan , D Pfeffer , V Tiwari , P Shripathi , P Russo

Abstract

Classic CAH is a rare condition characterized by cortisol deficiency and androgen excess, typically requiring treatment with supraphysiologic doses of glucocorticoids. This study evaluated the costs and identified key cost drivers for classic CAH in the United States (US).

More Publications

Role of Transdiagnostic Approach in Improving Quality of Life among Cancer Survivors: A Narrative Review.

Swati Sucharita Dash , Prangya Paramita , Tanushree Rao , Jignesh Bhate , Guruprasad KS Rao

Oct, 2024

ClinMed International Library

Economic Burden of Treatment-Resistant Depression

Swati Sucharita Dash , Merlin Roshma Sherin , Jignesh Bhate , Guruprasad KS Rao

Oct, 2024

Journal of Pharmacoeconomics and Pharmaceutical Management (JPPM)

Enhancing Healthcare Decision-Making: Comparison Between Health Technology Assessments and Access to Medical Care in a High-income Country vs. Low/middle Income Countries

Shashwati P , Arya K , Jignesh B , Guruprasad Rao KS

Mar, 2024

Health Technology Assessment (HTA) in Action